The Economist @TheEconomist
GLP1-agonists slow down the rate of “gastric emptying”, which means food stays in the stomach for longer, so people feel fuller and want to eat less. The drugs also affect the hypothalamus, the part of the brain that controls hunger https://t.co/aiTZL31BvS — PolitiTweet.org
